GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Abidi Laboratory (XTEH:ABDI1) » Definitions » Beta

Dr Abidi Laboratory (XTEH:ABDI1) Beta : N/A (As of Jun. 25, 2024)


View and export this data going back to . Start your Free Trial

What is Dr Abidi Laboratory Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-06-25), Dr Abidi Laboratory's Beta is Not available.


Dr Abidi Laboratory Beta Historical Data

The historical data trend for Dr Abidi Laboratory's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Abidi Laboratory Beta Chart

Dr Abidi Laboratory Annual Data
Trend
Beta

Dr Abidi Laboratory Semi-Annual Data
Beta

Competitive Comparison of Dr Abidi Laboratory's Beta

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Abidi Laboratory's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Abidi Laboratory's Beta Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dr Abidi Laboratory's Beta distribution charts can be found below:

* The bar in red indicates where Dr Abidi Laboratory's Beta falls into.



Dr Abidi Laboratory Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Dr Abidi Laboratory  (XTEH:ABDI1) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Dr Abidi Laboratory Beta Related Terms

Thank you for viewing the detailed overview of Dr Abidi Laboratory's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Abidi Laboratory (XTEH:ABDI1) Business Description

Traded in Other Exchanges
N/A
Address
Karaj Special Road, Kilometer 8 of Shahid Lashkari Highway, No. 72, Obedi Boulevard, Tehran, IRN
Dr Abidi Laboratory is engaged in manufacturing drugs and pharmaceutical products. The company offers products for anti-virus, oncology, respiratory, diabetes, rheumatology, digestion, and other diseases.

Dr Abidi Laboratory (XTEH:ABDI1) Headlines

No Headlines